All codes
X155
X155 – Subsequent test - high-risk patient or therapy monitoring - two or more sites
OHIP Diagnostic Radiology Code — DIAGNOSTIC RADIOLOGY · Schedule of Benefits
Subsequent bone mineral density (BMD) test, two or more sites, for a high-risk patient or for therapy monitoring (once every 36 months). The Schedule's high-risk thresholds for osteoporosis pharmacotherapy are: 1. T-score ≤ -2.5 at the lumbar spine, femoral neck or total hip; 2. previous hip or spine fracture, or ≥ 2 other fracture events; or 3. estimated 10-year fracture risk ≥ 15% using the fracture risk assessment tool (FRAX) or an equivalent major osteoporotic fracture assessment tool. A non-high-risk patient is one who meets none of these thresholds.
Referral requiredFrom: Physician, NursePractitioner, OralMaxillofacialSurgeon
Usage limits
For a high-risk patient, a maximum of one test every 36 months following the baseline test (X145/X146) or any subsequent test (X142/X148/X149/X155) or any additional test (X236/X237). For therapy monitoring, one test not earlier than 36 months after initiating pharmacotherapy and/or one test not earlier than 36 months after stopping bisphosphonate therapy.
Ready to bill this code?
SnapBill makes OHIP billing simple — auto-filled codes, validation, and batch submission.